Dow Rallies, Oil Retreat
Stocks rebounded on Monday as investors were optimistic that the conflict between Israel and Iran may remain contained. The spike in oil prices due to the escalating conflict also eased.The Dow Jones Industrials zoomed 365.95 points to 42,563.24.The S&P 500 index regrouped 61.02 points, or 1%, to 6,037.99.The NASDAQ Composite revived 286.3 points, or 1.5%, to 19,693.12.“Magnificent Seven” stocks were higher Monday as the pullback in oil prices caused investors to take on more risk again. Tesla was up more than 1%, and Meta Platforms increased about 3%. Meanwhile, Palantir, which is viewed as a beneficiary of increasing global conflict, moved more than 4% higher.Investors also digested weaker-than-expected manufacturing survey data Monday morning, which came ahead of the Federal Reserve’s interest rate decision on Wednesday.Traders have been closely watching the Middle East after Israel’s strike on Iran Friday. Iran launched missiles in retaliation, increasing the severity of conflict in the region.However, there was some optimism on Monday that the situation wouldn’t escalate after a Wall Street Journal report said that Iran has signaled through intermediaries that it would be open to restarting negotiations as long as U.S. doesn’t join Israel in the attacks. The report also said Iran has messaged to Israel that both sides should keep attacks contained.Prices for the 10-year Treasury were flat, maintaining yields at Friday’s 4.41%. Treasury prices and yields move in opposite directions. Oil prices slumped $1.91 to $71.07 U.S. a barrel. Gold prices slid $31.90 to $3,420.90 U.S. an ounce.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


